Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
0.9100
-0.0100 (-1.09%)
NASDAQ · Last Trade: Apr 3rd, 6:30 PM EDT

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.
Via MarketBeat · November 29, 2024

Via Benzinga · November 19, 2024

Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering.
Via Benzinga · October 9, 2024

Via Benzinga · October 9, 2024

CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

On Wednesday, 200 companies hit new 52-week lows.
Via Benzinga · October 19, 2022

During Friday's session, 198 companies made new 52-week lows.
Key Facts About Today's 52-Week Highs And Lows:
Alibaba Group Holding (NYSE:BABA) is the largest...
Via Benzinga · March 11, 2022

Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Via News Direct · June 17, 2024

Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics
Via News Direct · May 28, 2024

CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 14, 2024

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Via Benzinga · May 14, 2024

CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 2, 2024
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies.
Via Talk Markets · January 31, 2024
Cardiol Therapeutics (NASDAQ: CRDL)
Advancements in Therapies for Inflammatory Heart Diseases
--News Direct--
Via News Direct · October 13, 2023

697,000 people die from heart disease every year in the United States – that is one in every five deaths.
Via Benzinga · October 12, 2023

On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in Cardiol's novel CRD-38 subcutaneous (SUBQ) formulati
Via Benzinga · October 10, 2023

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.
Via Benzinga · September 21, 2023

During Tuesday's session, 78 companies made new 52-week lows.
Via Benzinga · October 18, 2022

On Tuesday, 44 companies hit new 52-week lows.
Via Benzinga · October 4, 2022

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.
Via Benzinga · May 19, 2022

The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) from Cardiol Therapeutics Inc. (NASDAQ: CRDL) to start a Phase 2 open-label pilot study designed to evaluate the tolerance and safety of CardiolRx, in patients with recurrent pericarditis.
Via Benzinga · May 17, 2022

Gainers
Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via Benzinga · April 19, 2022

Gainers
Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....
Via Benzinga · April 18, 2022

Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via Benzinga · April 18, 2022

Upgrades
Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,...
Via Benzinga · March 17, 2022